TATA AIA LIFE INSURANCE CO LTD WHOLE LIFE MID CAP EQUITY FUND ULIF 009 04/01/07 WLE 110
Institution · data to Jun 2026
Disclosed value
₹4,944 Cr
Jun 2026 closes
At current prices
…
Current holdings
6
Tracked since
Dec 2016
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| One 97 Communications Ltd | 1.75% | 0.05 | ₹1,367 Cr |
| PB Fintech Ltd | 1.84% | 0.55 | ₹1,352 Cr |
| IndusInd Bank Ltd | 1.11% | NEW | ₹800 Cr |
| Ajanta Pharma Ltd | 1.90% | 0.13 | ₹791 Cr |
| Krishna Institute of Medical Sciences Ltd | 1.57% | 0.13 | ₹562 Cr |
| Archean Chemical Industries Ltd | 1.06% | 0.39 | ₹71 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, TATA AIA LIFE INSURANCE CO LTD WHOLE LIFE MID CAP EQUITY FUND ULIF 009 04/01/07 WLE 110 — an institution tracked through public shareholding filings — disclosed 6 holdings in Indian listed companies worth ₹4,944 crore. The same holdings-at-filing-value basis put it at ₹3,381 crore in Mar 2026 (+46.2%). Solomo carries these filings back to Dec 2016.
Largest disclosed positions in Jun 2026: One 97 Communications Ltd (PAYTM — 1.75% of the company, ₹1,367 crore); PB Fintech Ltd (POLICYBZR — 1.84% of the company, ₹1,352 crore); IndusInd Bank Ltd (INDUSINDBK — 1.11% of the company, ₹800 crore); Ajanta Pharma Ltd (AJANTPHARM — 1.90% of the company, ₹791 crore); Krishna Institute of Medical Sciences Ltd (KIMS — 1.57% of the company, ₹562 crore). Those 5 account for 99% of the disclosed value.
Changes in the Jun 2026 filings: newly disclosed — IndusInd Bank Ltd. Stake raised in PB Fintech Ltd (+0.55 pp), Ajanta Pharma Ltd (+0.13 pp), Krishna Institute of Medical Sciences Ltd (+0.13 pp). Stake reduced in Archean Chemical Industries Ltd (−0.39 pp), One 97 Communications Ltd (−0.05 pp). No longer disclosed after the previous quarter: Timken India Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹4,944 Cr | +46.2% |
| Mar 2026 | ₹3,381 Cr | +115.8% |
| Dec 2025 | ₹1,567 Cr | −2.3% |
| Sep 2025 | ₹1,604 Cr | −46.2% |
| Jun 2025 | ₹2,980 Cr | +25.8% |
| Mar 2025 | ₹2,368 Cr | −16.7% |
| Dec 2024 | ₹2,844 Cr | +9.2% |
| Sep 2024 | ₹2,603 Cr | +17.4% |